Published in Br J Cancer on December 01, 1991
Photodynamic ablation of early cancers of the stomach by means of mTHPC and laser irradiation: preliminary clinical experience. Gut (1998) 1.67
Laser-induced fluorescence studies of meso-tetra(hydroxyphenyl)chlorin in malignant and normal tissues in rats. Br J Cancer (1994) 1.08
Photodynamic therapy as adjuvant therapy in surgically treated pleural malignancies. Br J Cancer (1997) 1.02
Mechanisms for optimising photodynamic therapy: second-generation photosensitisers in combination with mitomycin C. Br J Cancer (1995) 0.97
Foscan uptake and tissue distribution in relation to photodynamic efficacy. Br J Cancer (2003) 0.94
Photodynamic therapy effect of m-THPC (Foscan) in vivo: correlation with pharmacokinetics. Br J Cancer (2003) 0.91
Interstitial photodynamic laser therapy in interventional oncology. Eur Radiol (2004) 0.90
Photodynamic therapy for malignant tumours of the ampulla of Vater. Gut (1995) 0.89
Photodynamic therapy using intravenous delta-aminolaevulinic acid-induced protoporphyrin IX sensitisation in experimental hepatic tumours in rats. Br J Cancer (1996) 0.89
Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies. Cancer Metastasis Rev (2015) 0.89
Photodynamic therapy of a transplanted pancreatic cancer model using meta-tetrahydroxyphenylchlorin (mTHPC). Br J Cancer (1997) 0.88
Effects of photodynamic therapy on xenografts of human mesothelioma and rat mammary carcinoma in nude mice. Br J Cancer (1994) 0.87
Distribution and photodynamic effects of meso-tetrahydroxyphenylchlorin (mTHPC) in the pancreas and adjacent tissues in the Syrian golden hamster. Br J Cancer (1996) 0.86
Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model. Br J Cancer (1999) 0.83
Foscan (mTHPC) photosensitized macrophage activation: enhancement of phagocytosis, nitric oxide release and tumour necrosis factor-alpha-mediated cytolytic activity. Br J Cancer (1999) 0.82
Efficacy of intravenous delta-aminolaevulinic acid photodynamic therapy on rabbit papillomas. Br J Cancer (1995) 0.82
Assessment of effect of photosensitizers on cytotoxicity of photodynamic therapy in human breast cancer cell cultures. Arch Gynecol Obstet (1995) 0.81
Photodynamic Therapy for Cancer and for Infections: What Is the Difference? Isr J Chem (2012) 0.79
Malignant mesothelioma: new insights into tumour biology and immunology as a basis for new treatment approaches. Thorax (1995) 0.79
Synthesis, spectroscopic, and in vitro photosensitizing efficacy of ketobacteriochlorins derived from ring-B and ring-D reduced chlorins via pinacol-pinacolone rearrangement. J Org Chem (2011) 0.78
Photodynamic therapy with mTHPC and polyethylene glycol-derived mTHPC: a comparative study on human tumour xenografts. Br J Cancer (1999) 0.77
Minimally-invasive debulking of ovarian cancer in the rat pelvis by means of photodynamic therapy using the pegylated photosensitizer PEG-m-THPC. Br J Cancer (1999) 0.75
Photodynamic therapy for cancer. BMJ (1992) 0.75
P2X7 receptor as a novel drug delivery system to increase the entrance of hydrophilic drugs into cells during photodynamic therapy. J Bioenerg Biomembr (2016) 0.75
Intraoperative photodynamic therapy for malignant mesothelioma. Ann Thorac Surg (1990) 1.77
Technique of photodynamic therapy for disseminated intraperitoneal malignant neoplasms. Phase I study. Arch Surg (1991) 1.34
Photosensitizing efficiencies, tumor- and cellular uptake of different photosensitizing drugs relevant for photodynamic therapy of cancer. Photochem Photobiol (1987) 1.17
Chlorin and porphyrin derivatives as potential photosensitizers in photodynamic therapy. Photochem Photobiol (1991) 1.16
Malignant mesothelioma. The Eastern Cooperative Oncology Group (ECOG) experience. Cancer (1983) 1.07
Photodynamic therapy in patients with colorectal cancer. Cancer (1986) 1.01
Intraoperative photodynamic therapy for retroperitoneal sarcomas. Cancer (1988) 1.00
Photodynamic therapy for human malignant mesothelioma in the nude mouse. J Surg Res (1990) 0.97
Transthoracic endoscopic photodynamic treatment of malignant mesothelioma. Lancet (1991) 0.93
Surgical treatment of asbestos-related disease of the chest. Surg Clin North Am (1988) 0.88
The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res (2008) 52.43
The Ribosomal Database Project (RDP-II): sequences and tools for high-throughput rRNA analysis. Nucleic Acids Res (2005) 24.85
The Ribosomal Database Project (RDP-II): previewing a new autoaligner that allows regular updates and the new prokaryotic taxonomy. Nucleic Acids Res (2003) 18.64
The ribosomal database project (RDP-II): introducing myRDP space and quality controlled public data. Nucleic Acids Res (2006) 16.26
A method for testing for synergy with any number of agents. J Infect Dis (1978) 9.52
Effect of computer-based alerts on the treatment and outcomes of hospitalized patients. Arch Intern Med (1994) 8.20
Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature (1998) 7.26
Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal Biochem (1980) 5.45
Characteristics and physiological role of the Ca(2+)-activated Cl- conductance in smooth muscle. Am J Physiol (1996) 4.44
Cbfa2 is required for the formation of intra-aortic hematopoietic clusters. Development (1999) 4.21
Effect of mobile phone intervention for diabetes on glycaemic control: a meta-analysis. Diabet Med (2011) 4.04
Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2. Med Care (1996) 3.96
Is azathioprine a better immunosuppressive than 6-mercaptopurine? Clin Exp Immunol (1971) 3.47
Nature of the hepatomegalic effect produced by ethyl-chlorophenoxy-isobutyrate in the rat. Nature (1965) 3.30
EphA2 overexpression causes tumorigenesis of mammary epithelial cells. Cancer Res (2001) 3.24
Identification of intact peanut lectin in peripheral venous blood. Lancet (1998) 3.11
Tetrodotoxin-resistant dendritic spikes in avian Purkinje cells. Proc Natl Acad Sci U S A (1976) 3.10
CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling. Oncogene (2011) 3.08
Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor. Mol Cell Biol (1993) 3.07
A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains. RNA (2000) 3.06
The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci (1995) 2.99
The structure of bilirubin. Proc R Soc Lond B Biol Sci (1978) 2.98
Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation (2000) 2.95
Synergy, additivism and antagonism in immunosuppression. A critical review. Clin Exp Immunol (1977) 2.89
Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nat Genet (1996) 2.87
The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression. Br J Cancer (2001) 2.67
Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene. Nat Genet (1997) 2.64
Postoperative depression of the lymphocyte response to phytohaemagglutinin. Lancet (1967) 2.57
Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses. Neuron (2000) 2.50
Criteria for analyzing interactions between biologically active agents. Adv Cancer Res (1981) 2.49
Alternate splicing produces a novel cyclin D1 transcript. Oncogene (1995) 2.48
Translocation of SAPK/JNK to mitochondria and interaction with Bcl-x(L) in response to DNA damage. J Biol Chem (2000) 2.44
Correlated morphometric and biochemical studies on the liver cell. II. Effects of phenobarbital on rat hepatocytes. J Cell Biol (1969) 2.41
The structure of triphosphoinositide from beef brain. Biochim Biophys Acta (1966) 2.41
Autophosphorylation in the activation loop is required for full kinase activity in vivo of human and yeast eukaryotic initiation factor 2alpha kinases PKR and GCN2. Mol Cell Biol (1998) 2.39
Secular trends in the prevalence of general and abdominal obesity among Chinese adults, 1993-2009. Obes Rev (2011) 2.36
Multiple NF-kappaB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene. J Biol Chem (1998) 2.35
Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells. Proc Natl Acad Sci U S A (2001) 2.33
Presenilin-1 and -2 are molecular targets for gamma-secretase inhibitors. J Biol Chem (2000) 2.33
Multiple mechanisms of Na+ channel--linked long-QT syndrome. Circ Res (1996) 2.29
Characteristics of chloride currents activated by noradrenaline in rabbit ear artery cells. J Physiol (1990) 2.29
Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway. Nat Genet (1996) 2.26
Lactation is associated with greater maternal bone size and bone strength later in life. Osteoporos Int (2011) 2.19
Surveillance of the first case of human avian influenza A (H7N9) virus in Beijing, China. Infection (2013) 2.18
Three 4-coumarate:coenzyme A ligases in Arabidopsis thaliana represent two evolutionarily divergent classes in angiosperms. Plant J (1999) 2.14
MD-2 enables Toll-like receptor 2 (TLR2)-mediated responses to lipopolysaccharide and enhances TLR2-mediated responses to Gram-positive and Gram-negative bacteria and their cell wall components. J Immunol (2001) 2.12
Atomistic free-volume zones and inelastic deformation of metallic glasses. Nat Mater (2010) 2.08
Detection of exon deletions and duplications of the mismatch repair genes in hereditary nonpolyposis colorectal cancer families using multiplex polymerase chain reaction of short fluorescent fragments. Cancer Res (2000) 2.06
The expected effect of a combination of agents: the general solution. J Theor Biol (1985) 2.06
CXCR-4 (Fusin), a co-receptor for the type 1 human immunodeficiency virus (HIV-1), is expressed in the human brain in a variety of cell types, including microglia and neurons. Am J Pathol (1997) 2.00
The relationship between opsin overexpression and photoreceptor degeneration. Invest Ophthalmol Vis Sci (2001) 1.98
Olfactory neuroblastoma. An immunohistochemical, ultrastructural, and flow cytometric study. Cancer (1995) 1.97
Large scale association analysis for identification of genes underlying premature coronary heart disease: cumulative perspective from analysis of 111 candidate genes. J Med Genet (2004) 1.94
Malignant cells are collected on circular staplers. Dis Colon Rectum (1992) 1.94
The meso-reactivity of porphyrins and related compounds. VI. Oxidative cleavage of the haem system. The four isomeric biliverdins of the IX series. J Chem Soc Perkin 1 (1973) 1.92
Hypertension and retinopathy, arteriolar narrowing, and arteriovenous nicking in a population. Arch Ophthalmol (1994) 1.91
KCNE1 mutations cause jervell and Lange-Nielsen syndrome. Nat Genet (1997) 1.90
A consensus sequence for binding of Lrp to DNA. J Bacteriol (1995) 1.88
The mechanisms of severe arterial injury in surgery of the hip joint. Clin Orthop Relat Res (1979) 1.88
Hypersensitivity in mice. I. Induction of contact sensitivity to oxazolone and inhibition by various chemical compounds. Int Arch Allergy Appl Immunol (1970) 1.86
Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11. Cell (1996) 1.84
In vivo biological activity of the components of haematoporphyrin derivative. Br J Cancer (1982) 1.82
High-performance liquid chromatography of naturally occurring 8-, 7-, 6-, 5- and 4-carboxylic porphyrin isomers. J Chromatogr (1983) 1.77
The porphyrin pigmentation of subspecies of Bacteroides melaninogenicus. Biochem J (1979) 1.77
Action of niflumic acid on evoked and spontaneous calcium-activated chloride and potassium currents in smooth muscle cells from rabbit portal vein. Br J Pharmacol (1994) 1.73
Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan. Int J Cancer (1996) 1.71
Controlled multicenter trial of laparoscopic transabdominal preperitoneal hernioplasty vs Shouldice herniorrhaphy. Early results. Surg Endosc (1996) 1.71
Mutational spectrum of the TSC1 gene in a cohort of 225 tuberous sclerosis complex patients: no evidence for genotype-phenotype correlation. J Med Genet (1999) 1.71
Barriers to compliance with screening guidelines for diabetic retinopathy. Ophthalmic Epidemiol (1999) 1.69
Epidemiology of alveolar echinococcosis with particular reference to China and Europe. Parasitology (2003) 1.69
Mutant p53 cooperates with ETS and selectively up-regulates human MDR1 not MRP1. J Biol Chem (2001) 1.67
Plk3 functionally links DNA damage to cell cycle arrest and apoptosis at least in part via the p53 pathway. J Biol Chem (2001) 1.66
Randomized clinical trial to compare the effects of preoperative oral carbohydrate versus placebo on insulin resistance after colorectal surgery. Br J Surg (2010) 1.65
Copper resistance gene homologs in pathogenic and saprophytic bacterial species from tomato. Appl Environ Microbiol (1990) 1.65
Sucrose transport into barley seeds: molecular characterization of two transporters and implications for seed development and starch accumulation. Plant J (2000) 1.64
Oral mucosal melanomas: the WESTOP Banff workshop proceedings. Western Society of Teachers of Oral Pathology. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1997) 1.63
Phosphorylation of nuclear MyoD is required for its rapid degradation. Mol Cell Biol (1998) 1.61
Plasma protein (albumin) catabolism by the tumor itself--implications for tumor metabolism and the genesis of cachexia. Crit Rev Oncol Hematol (1997) 1.60
The synthesis of oligoribonucleotides. Part XI. Preparation of ribonucleoside 2'-acetal 3'-esters by selective deacylation. J Chem Soc Perkin 1 (1975) 1.59
The IPL gene on chromosome 11p15.5 is imprinted in humans and mice and is similar to TDAG51, implicated in Fas expression and apoptosis. Hum Mol Genet (1997) 1.56
Photodynamic destruction of human bladder carcinoma. Br J Cancer (1975) 1.55
Gastric hyperplasia in mice lacking the putative Cdc42 effector IQGAP1. Mol Cell Biol (2000) 1.55
MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma. Oncogene (2012) 1.55
Vision through cataracts. Invest Ophthalmol Vis Sci (1978) 1.54
Harmonization of vascular surgical training in Europe. A task for the European Board of Vascular Surgery (EBVS). Cardiovasc Surg (2000) 1.53
Cerebral photosensitisation by haematoporphyrin derivative. Evidence for an endothelial site of action. Br J Cancer (1986) 1.53
New mutations in the KVLQT1 potassium channel that cause long-QT syndrome. Circulation (1998) 1.53
The epidemiology of epiretinal membranes. Trans Am Ophthalmol Soc (1994) 1.51
The effect of liver transplantation in a 13-year-old boy with erythropoietic protoporphyria. Transplantation (1988) 1.51
The first step in vision occurs in femtoseconds: complete blue and red spectral studies. Proc Natl Acad Sci U S A (1993) 1.50
Sorafenib combined with percutaneous radiofrequency ablation for the treatment of medium-sized hepatocellular carcinoma. Eur Rev Med Pharmacol Sci (2015) 1.50
Structure of bilirubin. Nature (1976) 1.48
Time-dependent immunosuppressive effects of anti-thymocyte serum. Nature (1967) 1.48
meso-Tetra(hydroxyphenyl)porphyrins, a new class of potent tumour photosensitisers with favourable selectivity. Br J Cancer (1986) 1.47
Cloning of the mouse BTG3 gene and definition of a new gene family (the BTG family) involved in the negative control of the cell cycle. Leukemia (1997) 1.47
The oculocardiac reflex in cataract surgery in the elderly. Br J Ophthalmol (1997) 1.47